Hypertension Journal

Register      Login

VOLUME 1 , ISSUE 2 ( October-December, 2015 ) > List of Articles

REVIEW ARTICLE

Risk Assessment in Young Hypertensives

Niteen V Deshpande

Keywords : Cardiovascular risk assessment,Risk markers,Young hypertensives

Citation Information : Deshpande NV. Risk Assessment in Young Hypertensives. Hypertens J 2015; 1 (2):94-99.

DOI: 10.5005/jp-journals-10043-0016

Published Online: 00-12-2015

Copyright Statement:  Copyright © 2015; Jaypee Brothers Medical Publishers (P) Ltd.


Abstract

How to cite this article

Deshpande NV. Risk Assessment in Young Hypertensives. Hypertens J 2015;1(2):94-99.


PDF Share
  1. Hypertension in India: a systematic review and meat-analysis of prevalence, awareness and control of hypertension. J Hypertension 2014;32:1170-1177.
  2. Trends in hypertension epidemiology in India. J Human Hypertension 2004;18:73-78.
  3. un.org/unsd/demographic/products/dyb/dyb2.htm.
  4. Blood pressure matters, even during young adulthood. J Am Coll Cardiol 2011;58: 2404-2405.
  5. Interpreting blood pressure in young adults. J Am Coll Cardiol 2015;65:336-338.
  6. Isolated systolic hypertension in young and middle aged adults and 31 years risk for cardiovascular mortality. The Chicago Heart Association Detection Project in Industry Study. J Am Coll Cardiol 2015;65:327-335.
  7. Blood pressure in early adulthood, hypertension in middle age and future cardiovascular disease mortality Harvard Alumni Health Study (HAHS). J Am Coll Cardiol 2011;58:2396-2403.
  8. Blood pressure in young adulthood and mortality from cardiovascular disease. Res Letter Lancet 2000;355:1430-1431.
  9. Cardiovascular risk prediction: basic concepts, current status, and future directions. Circulation 2010;121:1768-1777.
  10. General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation 2008;117:743-753.
  11. Estimation of 10 years risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J 2003;24:987-1003.
  12. 2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines. Circulation 2014;129(suppl 2):S49-S72.
  13. Joint British Societies’ consensusrecommendations for the prevention of cardiovascular disease (JBS3). Heart 2014;100:ii1–ii67.
  14. Predicting cardiovascular risk in England and Wales: prospective derivation and validation of QRISK2. BMJ 2008;336:a332.
  15. Relationship between different cardiovascular risk score and measures of subclinical atherosclerosis in an Indian population. Ind Heart J 2015;67:332-340.
  16. Risk prediction is improved by adding markers of subclinical organ damage to SCORE. Eur Heart J 2010;31:883-891.
  17. Prevention of cardiovascular disease. Trends Cardiovasc Med 2015;25:436-442.
  18. INTERHEART study investigators. obesity and risk of myocardial infarction in 27000 participants from 52 countries: a case control study. Lancet 2005;366: 1640-1649.
  19. Relation of central obesity and insulin resistance with high diabetes prevalence and cardiovascular risk in south Asians. Lancet 1991;337:382-386.
  20. Cutoff values normal anthropometric variables in Asian Indian adults. Diabetes Care 2003;26:1380-1384.
  21. International Diabetes Federation 2005. Available at: http://www.idf.org/home.
  22. Arterial stiffness as surrogate end point-needed clinical trials. Hypertens 2012;60: 518-522.
  23. Prediction of cardiovascular events and all-cause mortality with arterial stiffness: a systematic review and meta-analysis. J Am Coll Cardiol 2010;55:1318-1327.
  24. Arterial stiffness and risk of coronary heart disease and stroke: the Rotterdam heart study. Circulation 2006;113:657-663.
  25. Aortic stiffness is an independent predictor of primary coronary events in hypertensive patients—a longitudinal study. Hypertens 2002;39:10-15.
  26. Arterial stiffness and cardiovascular events—the Framingham heart study. Circulation 2010;121:505-511.
  27. Predicative value of pulse wave velocity for cardiovascular events in 15520 subjects: an individual participant meta-analysis on behalf of the PWV collaborative group. J Hypertens 2010;28(Suppl A):E466.
  28. Long-term reduction in aortic stiffness: a 5.3 years follow-up in routine clinical practice. J Hypertens 2010;28:2336-2341.
  29. High sensitivity C-reactive protein: potential adjunct for global risk assessment in the primary prevention of cardiovascular disease. Circulation 2001;103:1813-1818.
  30. Comparison of c-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Eng J Med 2002;347:1557-1565.
  31. C-reactive protein and 10-year incidence of coronary heart disease in older men and women: the cardiovascular health study. Circulation 2005;112:25-31.
  32. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Eng J Med 2008;359:2195-2207.
  33. The task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2013;31:1281-1357.
  34. Common carotid intima media thickness and risk of stroke and myocardial infarction: the Rotterdam study. Circulation 1997:96:1432-1437.
  35. Risk prediction is improved by adding markers of sub clinical organ damage to SCORE. Eur Heart J 2010;31:883-891.
  36. Carotid artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular health study collaborative research group. N Eng J Med 199;340:14-22.
  37. Systolic and diastolic blood pressure, pulse pressure and mean arterial pressure as predictors of cardiovascular disease risk in men. Hypertension 2000;36:801-807.
  38. Calcium antagonist lacidipine slows down progression of asymptomatic carotid atherosclerosis. Principal results of the European lacidipine study of atherosclerosis (ELSA) a randomized double blind long-term trial. Circulation 2002;106:2422-2427.
  39. Carotid intima-media thickness and presence or absence of plaque improves prediction of coronary heart disease risk: the atherosclerosis risk in communities (ARIC) study. J Am Coll Cardiol 2010;55:1600-1607.
  40. Improvements in risk stratification for the occurrence of cardiovascular disease by imaging subclinical atherosclerosis: a systematic review. Heart 2012;98:177-184.
  41. The long-term prognostic value of the resting and post-exercise ankle brachial index. Arch Intern Med 2006;166:529-535.
  42. Ankle brachial index combined with Framingham risk score to predict cardiovascular events and mortality: a meta-analysis. JAMA 2008;300: 197-208.
  43. Arterial hypertension, microalbuminuria and risk of ischemic heart disease. Hypertens 2000;35:898-903.
  44. Association of cardiovascular risk factors with microalbuminuria in hypertensive Risk Assessment in Young Hypertensives individuals: the i-SEARCH global study. J Hypertens 2007;25: 2317-2324.
  45. Reduction in albuminuria translets to reduction in cardiovascular events in hypertensive patients. Losartan intervention for endpoint reduction in hypertension study. Hypertens 2005;45:198-202.
  46. Changes in renal resistive index and urinary albumin excretion in hypertensive patients under long-term treatment with lisinopril or Nifedipine GITS. Nephron 2002;90:169-173.
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.